Taineisha Bolden
Family Medicine · Durham, NCNPI 1164699500
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $454 and has fallen 96.4% since, to $16 in 2025.
Across 63 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$173
- Lilly USA, LLC$123
- AstraZeneca$107
- Johnson & Johnson$94
- Novo Nordisk$81
- Takeda Pharmaceuticals U.S.A., Inc.$75
- plus $407 from 14 others
What the payments were for
- Food & beverage$1,060100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 10 | $173 |
| Lilly USA, LLC | 7 | $123 |
| AstraZeneca | 7 | $107 |
| Johnson & Johnson | 6 | $94 |
| Novo Nordisk | 6 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Jazz Pharmaceuticals Inc. | 4 | $71 |
| Pfizer | 4 | $69 |
| AbbVie | 4 | $66 |
| Boehringer Ingelheim | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Medtronic | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Gilead | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Cranial Technologies, Inc | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$1,060 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 11 | $12,665 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $11,203 |
| OxycontinOxycodone Hcl | 13 | $8,637 |
| Oxycodone Hcl | 39 | $1,252 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $156 |
| Alprazolam | 24 | $92 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Durham
- Margie SanderDurham$63K
- Devdutta SangvaiDurham$31K
- Linda BissonnetteDurham$21K
- John Ragsdale IiiDurham$20K
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.